Vera Therapeutics, Inc.

Nasdaq VERA · Brisbane, CA

Works in Dermatology · Immunology · Renal & urogenital · Women's health

Vera Therapeutics, Inc. is a clinical trial sponsor based in Brisbane, CA, listed as Nasdaq VERA. It has 4 active clinical trials with 1,518 planned participants, in Dermatology, Immunology, Renal & urogenital and Women's health. Since 2021 it has completed 1 trial and stopped 1 early. Its FDA record on file shows compliance actions.

Trial track record · since 2021

4Active trials1,518 planned participants
1Completed2 with results posted
1Stopped earlyterminated, withdrawn or suspended

FDA record

0InspectionsNone posted since 2025
0Warning lettersNone on file
0RecallsNone on file

Recent FDA actions

Financials · Nasdaq VERA

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 4 active trials

StageTrialStatus

On the market

1 approved drug application with a product on the market.

Questions about Vera Therapeutics, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-01.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with Vera Therapeutics, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.